Research Article

Association of Calcium and Phosphate Levels with Incident Chronic Kidney Disease in Patients with Hypoparathyroidism: A Retrospective Case-Control Study

Table 2

Association between albumin-corrected serum calcium and development of CKD.

Patients with CKD (n = 150), nControl patients without CKD (n = 150), nMatched groupsAdjusted analyses
Odds Ratio95% CI valueOdds Ratio95% CI value

Proportion of measurements outside of 2.00–2.25 mmol/L (8.0–9.0 mg/dL)
≥67%63273.391.81–6.38<0.0013.461.82–6.56<0.001
33% to <67%51621.400.75–2.610.291.360.72–2.560.34
<33%36611.00(Reference)1.00(Reference)

Proportion of measurements above 2.00–2.25 mmol/L (8.0–9.0 mg/dL)
≥67%25112.611.21–5.590.012.851.30–6.28<0.01
33% to <67%37311.470.85–2.530.171.530.87–2.700.14
<33%881081.00(Reference)1.00(Reference)

Proportion of measurements below 2.002.25 mmol/L (8.0–9.0 mg/dL)
≥67%26102.751.21–6.250.022.681.16–6.150.02
33% to <67%31370.780.43–1.420.420.710.38–1.330.29
<33%931031.00(Reference)1.00(Reference)

CCI: Charlson comorbidity index; CI: confidence interval; CKD: chronic kidney disease. Models were run for the proportion outside, above, and below the range. Matching for groups was 1:1 based on age ± 5 years, sex, index date ± 1 year, and exposure window duration. Adjusted models were adjusted for the following baseline characteristics: age (continuous variable), index year (continuous variable), race (White vs Black, Asian, multi, other, or unknown), hypertension, type 2 diabetes, any acute hypoparathyroidism event (event of cardiac dysrhythmia, hypercalcemia, hypocalcemia, laryngeal spasm, muscle spasm, other convulsions, palpitations, tachycardia, tetanic cataract, or tetany), and CCI. The target range for albumin-corrected serum calcium in patients with chronic hypoparathyroidism is defined as 2.00–2.25 mmol/L (8.0–9.0 mg/dL), which is different from the normal population reference range (2.15–2.55 mmol/L; 8.6–10.2 mg/dL). Denotes any value < 0.05.